2-(4-N-FMOC-MORPHOLIN-2-YL)ACETIC ACID, 95.0%, 1g

1-(2-(Difluoromethyl)phenyl)ethanol, 98%, 100mg

(4-(Propylsulfonyl)phenyl)boronic acid, 98%, 1g

(3S)-1-(Pyridin-2-yl)pyrrolidin-3-amine, 1g

4-Bromo-2-vinylpyridine, 95.0%, 5g

1,4,5,8-Tetrahydroxyanthracene-9,10-dione, 98%, 1g

2-hydroxy-3-(4-methoxyphenyl)prop-2-enoic acid, 97%, 100mg

9-[[2-(acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-2-amino-1,9-dihydro-6h-purin-6-one, 97%, 5g

3-BROMO-4-PHENYLPYRIDINE, 95.0%, 5g

Objectif Plan PLi 20x/0.40 IOS corrigé à l'infini

2,5-DIOXOPYRROLIDIN-1-YL 11-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROL-1-YL)UNDECANOATE, 95%, 100mg

Ethyl 4-iodobutanoate, 95.0%, 100g

4-Chloro-5-iodothieno[2,3-d]pyrimidine, 95.0%, 100mg